# reload+after+2024-01-21 20:43:33.837878
address1§3950 South Country Club Road
address2§Suite 470 4th Floor
city§Tucson
state§AZ
zip§85714
country§United States
phone§520 365 3100
website§https://acceleratediagnostics.com
industry§Medical Devices
sector§Healthcare
longBusinessSummary§Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. The company was incorporated in 1982 and is headquartered in Tucson, Arizona.
fullTimeEmployees§179
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Jack  Phillips', 'age': 57, 'title': 'CEO, President & Director', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 595000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Lawrence Michael Mertz', 'age': 61, 'title': 'Chief Technology Officer', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 329231, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David  Patience', 'age': 37, 'title': 'CFO, Principal Financial Officer & Principal Accounting Officer', 'yearBorn': 1986, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Maya  Gowri', 'title': 'Senior VP & Head of Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Laura  Pierson', 'title': 'Investor Relations Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Gretchen  Strohminger', 'title': 'Senior VP and Head of Human Resources & Culture', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. John  Meduri', 'title': 'Chief Strategy Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Kurtis  Montegna', 'title': 'Senior Vice President of Regulatory Affairs & Quality Assurance', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Chris  Thode', 'title': 'Senior Vice President of US Commercial', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Rita  Boukamel', 'title': 'Senior VP & Head of EMEA', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§10
boardRisk§3
compensationRisk§8
shareHolderRightsRisk§3
overallRisk§6
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.843
priceToSalesTrailing12Months§4.593912
currency§USD
dateShortInterest§1702598400
forwardEps§-2.03
pegRatio§-0.03
exchange§NCM
quoteType§EQUITY
shortName§Accelerate Diagnostics, Inc.
longName§Accelerate Diagnostics, Inc.
firstTradeDateEpochUtc§765725400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§a602e4de-ddad-3ecf-864d-d40f7da91eac
gmtOffSetMilliseconds§-18000000
targetHighPrice§5.0
targetLowPrice§5.0
targetMeanPrice§5.0
targetMedianPrice§5.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§0.63
grossMargins§0.22975999
ebitdaMargins§0.0
trailingPegRatio§None
